Effect of genetic variation in Notch regulator DTX1 on SCLC prognosis compared with the effect on NSCLC prongosis

Deltex‐1 (DTX1) is a negative regulator of the Notch signaling pathway. Here, we investigated the clinical effect of DTX1 rs1732786A > G, which is associated with better prognosis in patients with early‐stage non‐small cell lung cancer (NSCLC), in 261 patients with small cell lung cancer (SCLC)....

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Seung Soo, Lee, Jang Hyuck, Hong, Mi Jeong, Choi, Jin Eun, Kang, Hyo‐Gyoung, Do, Sook Kyung, Kim, Ji Hyun, Baek, Sun Ah, Choi, Sun Ha, Lee, Won Kee, Lee, Yong Hoon, Seo, Hyewon, Lee, Jaehee, Lee, Shin Yup, Cha, Seung Ick, Kim, Chang Ho, Park, Jae Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471053/
https://www.ncbi.nlm.nih.gov/pubmed/32700476
http://dx.doi.org/10.1111/1759-7714.13566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471053/
https://www.ncbi.nlm.nih.gov/pubmed/32700476
http://dx.doi.org/10.1111/1759-7714.13566

Ejemplares similares